DETROIT Are Americans ready to glimpse into the future of their health?
On May 27, researchers with the National Human Genome Research Institute (NHGRI) and the National Cancer Institute (NCI), along with Group Health Cooperative in Seattle and Henry Ford Health System, will debate and discuss that question during the one-day symposium "Multiplex Initiative: Implications for Personalized Medicine."
Media are invited to attend the symposium. It will be held from 7:30 a.m. 3:30 p.m. at Henry Ford Health System in Detroit.
Various implications for personalized medicine based on the four institutions' joint study, the Multiplex Initiative will be highlighted during the symposium:
If We Build It, Will They Come? Creating a Research Infrastructure for Multiplex Genetic Testing. Presented by Andy Baxevanis, NHGRI.
How to Build a Genetic Test in Five Easy Steps. Presented by Lawrence Brody, NHGRI.
Social Group Participating in the Multiplex Project. Presented by Sharon Hensley Alford, Henry Ford Hospital.
Profile of Multiplex Testers: Implications for Patient-Physician Interactions. Presented by Colleen McBride.
What Did Participants Want to Know about Multiplex Testing? Implications for Decisions Support Systems. Presented by Christopher Wade, NHGRI.
Informing Patients of their Genetic Risks: Effects on Health Care Seeking. Presented by Robert Reid and Eric Larson, Group Health Cooperative.
If Given a Choice, How Much and What Disease-Risk Feedback Would Participants Want? Presented by Barbara Biesecker, NHGRI.
Potential for Early Intervention; Parents' Views of Multiplex Testing for their Children. Presented by Ken Tercyak, Lombardi Comprehensive Cancer Center, Georgetown University.
The Multiplex Initiative investigated the interest level of healthy, young, insured adults in receiving genetic susceptibility testing for eight common conditions. The
|Contact: Krista Hopson|
Henry Ford Health System